FDA Adverse Event Malfunction Summary report: N

ARCHITECT PHOSPHORUS

MDR report key: 3761108 · Received April 21, 2014

Report

Report Number
1628664-2014-00078
Event Type
Malfunction
Date Received
April 21, 2014
Date of Event
March 27, 2014
Report Date
April 1, 2014
Manufacturer
ABBOTT MANUFACTURING INC
Product Code
JJE
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, A SEARCH FOR SIMILAR COMPLAINTS AND A REVIEW OF LABELING. NO ADVERSE TREND WAS IDENTIFIED FOR THE CUSTOMER'S ISSUE. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. THE SAMPLE WAS NOT REQUESTED TO BE RETURNED, DUE TO SAMPLE BEING REPEATED AT ANOTHER LAB WITH A DIFFERENT METHODOLOGY AND WAS CONFIRMED TO MATCH ARCHITECT CSYSTEM RESULT. BASED ON THE AVAILABLE INFORMATION, NO PRODUCT DEFICIENCY WAS IDENTIFIED.

Additional Manufacturer Narrative · 1

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. (B)(4). THE COMPLETE SID IS (B)(6). AN EVALUATION IS IN PROCESS.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED A FALSELY DEPRESSED PHOSPHORUS RESULT FOR ONE PATIENT ON THE ARCHITECT C16000 ANALYZER. THE FOLLOWING DATA WAS PROVIDED FOR SID (B)(6): ON (B)(6) 05:06 AM, RESULT <0.70 MG/DL ON PLASMA. ON (B)(6), 01:26 PM, RESULT = 0.72 MG/DL ON SERUM. ON (B)(6), 01:52 PM, RESULT = 0.82 MG/DL ON SERUM. REPEATED ON ANOTHER METHOD (ROCHE) AS 0.71 MG/DL. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
240455 ARCHITECT PHOSPHORUS CLINICAL CHEMISTRY PHOSPHORUS JJE ABBOTT MANUFACTURING INC 81317UN13

Patients

Seq Age Sex Outcome Treatment
1 LN 03L77-01 SN (B)(4)| ARCHITECT C16000 ANALYZER| ARCHITECT C16000 ANALYZER| LN 03L77-01 SN (B)(4)